Pulmonology Medical News about Interstitial lung disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Interstitial lung disease in collagen vascular diseases
Zeitschrift für Rheumatologie, 09/29/09

Schnabel A et al. – Therapeutic experience is heterogeneous but evidence is accumulating suggesting that NSIP in the collagen vascular diseases is amenable to immunosuppression. Rapid clinical and/or radiological deterioration, reflecting inflammatory activity, appears to mark those patients who are most likely to benefit from cyclophosphamide therapy.

<< Previous
Detection and susceptibility testing of Mycoplasma amphoriforme...

Next >>
Opportunist mycobacterial lung disease – which drug combination...

Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event
Lung Cancer, 11/16/09 Relevance Score: 81%

No evidence for interstitial lung oedema by extensive pulmonary function testing at 4559 m
European Respiratory Journal, 10/22/09 Relevance Score: 81%

Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease
Journal of Bronchology, 10/14/09 Relevance Score: 81%

Minor Salivary Gland Biopsy To Detect Primary Sjogren Syndrome in Patients With Interstitial Lung Disease
Chest, 10/09/09 Relevance Score: 80%

Interstitial inflammation in visceral organs is a pathologic feature of adult-onset Stills disease
Rheumatology International, 11/16/09 Relevance Score: 79%